ATG5 and nasopharyngeal carcinoma: Moreover, the investigation of combining autophagic inhibition (using CQ or genetic inhibition of ATG5) with RPA inhibition showed that this combination therapy is more effective in enhancing NPC’s antitumor response to radiation than monotherapy.